共 22 条
[1]
Avorn J., Chen M., Hartley R., Scientific versus commercial sources of influence on the prescribing behaviour of physicians, American Journal of Medicine, 73, pp. 4-8, (1982)
[2]
Avorn J., Soumerai S.B., Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based ‘detailing’, New England Journal of Medicine, 308, pp. 1457-1463, (1983)
[3]
Brody B., Wray N., Bame S., Ashton C., Petersen N., Et al., The impact of economic considerations on clinical decisionmaking: the case of thrombolytic therapy, Medical Care, 29, pp. 899-910, (1991)
[4]
Caudill T.S., Rich E.C., Johnson M., McKirmey P.W., Physicians, pharmaceutical representatives, and the cost of prescribing. Abstract, Clinical Research, 40, (1992)
[5]
Connelly D.P., Rich E.C., Curley S.P., Kelly J.T., Knowledge resource preferences of family physicians, Journal of Family Practice, 30, pp. 353-359, (1990)
[6]
Lancet, 2, pp. 23-24, (1987)
[7]
Frazier L.M., Brown J.T., Divine G.W., Fleming G.R., Philips N.M., Et al., Can physician education lower the cost of prescription drugs? A prospective, controlled trial, Annals of Internal Medicine, 115, pp. 116-121, (1991)
[8]
Frieden T.R., Mangi R.J., Inappropriate use of oral ciprofloxacin, Journal of the American Medical Association, 264, pp. 1438-1440, (1990)
[9]
Hall C.B., Douglas R.G., Influenza and infections of the trachea, bronchi and bronchioles, A practical approach to infectious diseases, pp. 184-198, (1991)
[10]
Harris B.L., Stergachis A., Ried L.D., The effect of drug copayments on utilization and cost of pharmaceuticals in a health maintenance organization, Medical Care, 28, pp. 907-917, (1990)